Suppr超能文献

75克口服葡萄糖耐量试验的糖尿病模式是丙型肝炎病毒患者肝细胞癌的一个危险因素。

Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.

作者信息

Konishi Ichiro, Hiasa Yoichi, Shigematsu Syuichiro, Hirooka Masashi, Furukawa Shinya, Abe Masanori, Matsuura Bunzo, Michitaka Kojiro, Horiike Norio, Onji Morikazu

机构信息

Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan.

出版信息

Liver Int. 2009 Sep;29(8):1194-201. doi: 10.1111/j.1478-3231.2009.02043.x. Epub 2009 Apr 28.

Abstract

BACKGROUND

Patients with hepatitis C virus (HCV) frequently show glucose intolerance. Diabetes mellitus (DM) has been proposed to be a risk factor for hepatocellular carcinoma (HCC).

AIMS

The aim of this study is to clarify the influence of glucose intolerance as evaluated by the 75 g oral glucose tolerance test (OGTT) on hepatocarcinogenesis in patients with HCV.

METHODS

This study was carried out in a cohort of 197 patients with HCV who had not been previously diagnosed as having DM. All patients underwent the 75 g OGTT at entry. They were also screened for HCC and, thereafter, the rate of hepatocarcinogenesis was compared between the patients with and without glucose intolerance.

RESULTS

Based on the results of the 75 g OGTT, 125 (63%) had normal glucose tolerance (NGT), 49 (25%) had impaired glucose tolerance (IGT) and 23 (12%) had the DM pattern. HCC occurred more frequently in patients with the DM pattern than in patients with either NGT or IGT. Even in patients without advanced liver fibrosis, HCC was more frequently observed in patients with DM than in patients with NGT. A multiple logistic regression analysis showed advanced liver fibrosis, the DM pattern on the 75 g OGTT, an older age and gamma-glutamyltransferase to all be independent risk factors related to hepatocarcinogenesis.

CONCLUSIONS

A DM pattern on the 75 g OGTT was thus found to be associated with hepatocarcinogenesis and the 75 g OGTT is considered to be useful for identifying this risk factor for HCC in patients with HCV.

摘要

背景

丙型肝炎病毒(HCV)患者常出现葡萄糖不耐受。糖尿病(DM)被认为是肝细胞癌(HCC)的一个危险因素。

目的

本研究旨在阐明通过75g口服葡萄糖耐量试验(OGTT)评估的葡萄糖不耐受对HCV患者肝癌发生的影响。

方法

本研究在197例既往未被诊断为DM的HCV患者队列中进行。所有患者在入组时均接受75g OGTT。他们还接受了HCC筛查,此后,比较了有和没有葡萄糖不耐受患者的肝癌发生率。

结果

根据75g OGTT结果,125例(63%)葡萄糖耐量正常(NGT),49例(25%)葡萄糖耐量受损(IGT),23例(12%)为DM型。DM型患者发生HCC的频率高于NGT或IGT患者。即使在没有晚期肝纤维化的患者中,DM患者发生HCC的频率也高于NGT患者。多因素逻辑回归分析显示,晚期肝纤维化、75g OGTT的DM型、年龄较大和γ-谷氨酰转移酶均为与肝癌发生相关的独立危险因素。

结论

因此发现75g OGTT的DM型与肝癌发生有关,75g OGTT被认为有助于识别HCV患者中HCC的这一危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验